首页 › 新冠后遗症（长新冠） › 北卡罗来纳州 › Durham
Durham NC 新冠后遗症（长新冠）临床试验
8项针对 新冠后遗症（长新冠）的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
招募中3 期
- Research Site, Durham
Long-Term Study of COVID-19 Infection and Long COVID
招募中观察性研究
- University of North Carolina, Chapel Hill · 距离 10 英里
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
招募中3 期
- Duke Vaccine and Trials Unit, Durham
- Duke Vaccine and Trials Unit, Durham
- Duke University - Main Hospital and Clinics, Durham
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
招募中观察性研究欢迎健康志愿者
- Duke University Health System, Durham
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
招募中4 期欢迎健康志愿者
- Duke Vaccine and Trials Unit, Durham
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
招募中3 期
- Duke University, Durham
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
招募中
- Duke University Health System, Durham
Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity
招募中观察性研究欢迎健康志愿者
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 距离 7 英里
其他城市的 新冠后遗症（长新冠）试验
- New York City, NY15 项研究
- Boston, MA13 项研究
- Houston, TX13 项研究
- Baltimore, MD12 项研究
- Chicago, IL11 项研究
- Washington, DC10 项研究
- Atlanta, GA8 项研究
- San Francisco, CA8 项研究
- San Diego, CA7 项研究
- Pittsburgh, PA6 项研究
- Hialeah, FL6 项研究
- Miami, FL6 项研究
Durham的其他研究
- 乳腺癌64 项研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 转移性癌症33 项研究
- 急性髓系白血病33 项研究
- 前列腺癌32 项研究
- 肺癌32 项研究
- 结直肠癌29 项研究
- 慢性淋巴细胞白血病27 项研究
- 卵巢癌27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。